These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21689914)

  • 1. Letter to Respiratory Medicine: "Drugs reducing transepithelial leukocyte traffic may worsen lung disease".
    Persson C; Uller L
    Respir Med; 2011 Dec; 105(12):1969. PubMed ID: 21689914
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients.
    Kerstjens HA; Bjermer L; Eriksson L; Dahlström K; Vestbo J
    Respir Med; 2010 Sep; 104(9):1297-303. PubMed ID: 20466530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on tiotropium.
    Tsakok AD
    Respir Med; 2010 Sep; 104(9):1388; author reply 1389. PubMed ID: 20627501
    [No Abstract]   [Full Text] [Related]  

  • 4. Fenspiride -14 C: its distribution, excretion and metabolism in the rat.
    Megel H; Holmes P; Zalipsky J; Shemano I; Beiler JM
    Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):90-9. PubMed ID: 4717391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of COPD. Reducing air trapping in the lung--improving physical capacity].
    MMW Fortschr Med; 2005 May; 147(19):54-5. PubMed ID: 15940941
    [No Abstract]   [Full Text] [Related]  

  • 6. AZD-4818, a chemokine CCR1 antagonist: WO2008103126 and WO2009011653.
    Norman P
    Expert Opin Ther Pat; 2009 Nov; 19(11):1629-33. PubMed ID: 19586423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging.
    De Backer J; Vos W; Vinchurkar S; Van Holsbeke C; Poli G; Claes R; Salgado R; De Backer W
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):88-99. PubMed ID: 25004168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms.
    van Noord JA; Aumann JL; Janssens E; Smeets JJ; Zaagsma J; Mueller A; Cornelissen PJ
    Respir Med; 2010 Jul; 104(7):995-1004. PubMed ID: 20303247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study.
    Cabrera C; Casanova C; Martín Y; Mirabal V; Sánchez Mdel C; Álvarez F; Juliá G; Cabrera-Navarro P; García-Bello MÁ; Marín JM; de-Torres JP; Divo M; Celli B
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1217-22. PubMed ID: 27354780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All that wheezes is not obstructive pulmonary disease.
    Cydulka RK
    Ann Emerg Med; 2008 Jan; 51(1):35-6. PubMed ID: 17719693
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.
    Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
    Pulm Pharmacol Ther; 2014 Aug; 28(2):158-64. PubMed ID: 24076367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
    LaForce C; Feldman G; Spangenthal S; Eckert JH; Henley M; Patalano F; D'Andrea P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1233-43. PubMed ID: 27354782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease.
    D'Urzo T; Donohue JF; Price D; Miravitlles M; Kerwin E
    Expert Rev Respir Med; 2015 Oct; 9(5):519-32. PubMed ID: 26366803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.
    Borel B; Wilkinson-Maitland CA; Hamilton A; Bourbeau J; Perrault H; Jensen D; Maltais F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2991-3000. PubMed ID: 27942208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in pharmacotherapy for dyspnea in COPD.
    Raghavan N; Webb K; Amornputtisathaporn N; O'Donnell DE
    Curr Opin Pharmacol; 2011 Jun; 11(3):204-10. PubMed ID: 21450522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensifying approach to the therapy of patients with constellation of the diseases: chronic obstructive pulmonary disease and osteoarthritis.
    Zhdan VN; Potyazhenko MМ; Khaymenova GS; Lyulka NN; Dubrovinskaya TV; Ivanitsky IV
    Wiad Lek; 2017; 70(3 pt 2):578-580. PubMed ID: 28713086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
    Adams SG; Anzueto A; Briggs DD; Menjoge SS; Kesten S
    Respir Med; 2006 Sep; 100(9):1495-503. PubMed ID: 16698259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute exacerbation of COPD].
    Füessl HS
    MMW Fortschr Med; 2014 Jan; 156(1):44-6. PubMed ID: 24930309
    [No Abstract]   [Full Text] [Related]  

  • 19. [Air trapping in COPD].
    Mitfessel H
    Krankenpfl J; 2005; 43(4-6):117. PubMed ID: 16171063
    [No Abstract]   [Full Text] [Related]  

  • 20. New physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients.
    Laveneziana P; Guenette JA; Webb KA; O'Donnell DE
    Expert Rev Respir Med; 2012 Dec; 6(6):651-62. PubMed ID: 23234451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.